{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:17:21Z","timestamp":1791865041531,"version":"4.3.4"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.canlet.2025.217714","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T21:59:10Z","timestamp":1744149550000},"page":"217714","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Metabolic reprogramming in cholangiocarcinoma cancer stem cells: Emerging therapeutic paradigms"],"prefix":"10.1016","volume":"622","author":[{"given":"Qi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanqing","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanrui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2025.217714_bib1","first-page":"198","article-title":"Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians","volume":"73","author":"Moris","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2025.217714_bib2","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.jhep.2022.07.022","article-title":"Current epidemiology of cholangiocarcinoma in Western countries","volume":"77","author":"Vithayathil","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2025.217714_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216799","article-title":"Characterization of the distinct immune microenvironments between hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"588","author":"Jiang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217714_bib4","article-title":"New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe","volume":"50","author":"Rimassa","year":"2025","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.canlet.2025.217714_bib5","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/gutjnl-2021-326514","article-title":"Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications","volume":"72","author":"Martin-Serrano","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.canlet.2025.217714_bib6","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.stem.2024.06.003","article-title":"Cancer stem cell mimicry for immune evasion and therapeutic resistance","volume":"31","author":"Saw","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2025.217714_bib7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ccr.2012.03.003","article-title":"Cancer stem cells: impact, heterogeneity, and uncertainty","volume":"21","author":"Magee","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2025.217714_bib8","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s12015-023-10557-7","article-title":"Reciprocal interaction of cancer stem cells of cholangiocarcinoma with macrophage","volume":"19","author":"Wang","year":"2023","journal-title":"Stem Cell Rev Rep"},{"key":"10.1016\/j.canlet.2025.217714_bib9","article-title":"Can we utilise the circadian clock to target cancer stem cells?","volume":"611","author":"Lian","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217714_bib10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12943-025-02265-2","article-title":"Cancer stem cells and niches: challenges in immunotherapy resistance","volume":"24","author":"Pan","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2025.217714_bib11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.stem.2024.04.004","article-title":"Hallmarks of cancer stemness","volume":"31","author":"Loh","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2025.217714_bib12","first-page":"546","article-title":"Circadian regulation of cancer stem cells and the tumor microenvironment during metastasis","volume":"5","author":"Wang","year":"2024","journal-title":"Nat. Can. (Ott.)"},{"key":"10.1016\/j.canlet.2025.217714_bib13","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1158\/0008-5472.CAN-23-0510","article-title":"Targeting CD44 variant 5 with an antibody-drug conjugate is an effective therapeutic strategy for intrahepatic cholangiocarcinoma","volume":"83","author":"Bei","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217714_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120427","article-title":"Inhibition of FGFR2 enhances chemosensitivity to gemcitabine in cholangiocarcinoma through the AKT\/mTOR and EMT signaling pathways","volume":"296","author":"Jaidee","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.canlet.2025.217714_bib15","article-title":"A combination therapy of bortezomib, CXCR4 inhibitor, and checkpoint inhibitor is effective in cholangiocarcinoma in vivo","volume":"26","author":"Li","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.canlet.2025.217714_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101229","article-title":"Overcoming cancer therapy resistance: from drug innovation to therapeutics","volume":"81","author":"Wei","year":"2025","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.canlet.2025.217714_bib17","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jhep.2022.04.038","article-title":"Metabolic reprogramming in cholangiocarcinoma","volume":"77","author":"Raggi","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2025.217714_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217108","article-title":"Targeting of human cancer stem cells predicts efficacy and toxicity of FDA-approved oncology drugs","volume":"599","author":"Vojnits","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217714_bib19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41575-021-00508-3","article-title":"Cancer stem cells in hepatocellular carcinoma - from origin to clinical implications","volume":"19","author":"Lee","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2025.217714_bib20","doi-asserted-by":"crossref","first-page":"552","DOI":"10.7150\/ijbs.76187","article-title":"Targeting breast cancer stem cells","volume":"19","author":"Zhang","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.canlet.2025.217714_bib21","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.stem.2019.11.015","article-title":"Outer radial glia-like cancer stem cells contribute to heterogeneity of glioblastoma","volume":"26","author":"Bhaduri","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2025.217714_bib22","first-page":"1347","article-title":"Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma","volume":"134","author":"Sell","year":"1989","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.canlet.2025.217714_bib23","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1158\/0008-5472.CAN-09-2823","article-title":"Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma","volume":"70","author":"Woo","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.217714_bib24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2045-3701-1-5","article-title":"Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine?","volume":"1","author":"Kumar","year":"2011","journal-title":"Cell Biosci."},{"key":"10.1016\/j.canlet.2025.217714_bib25","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s00534-012-0542-6","article-title":"Recent advances in cancer stem cell research for cholangiocarcinoma","volume":"19","author":"Kokuryo","year":"2012","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.canlet.2025.217714_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2184.2004.00297.x","article-title":"Hepatic stem cells: from inside and outside the liver?","volume":"37","author":"Alison","year":"2004","journal-title":"Cell Prolif."},{"key":"10.1016\/j.canlet.2025.217714_bib27","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1634\/theoncologist.12-3-320","article-title":"A case of an alpha-fetoprotein-producing intrahepatic cholangiocarcinoma suggests probable cancer stem cell origin","volume":"12","author":"Ishikawa","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.canlet.2025.217714_bib28","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1002\/jcp.25797","article-title":"Epithelial-mesenchymal transition (EMT): a biological process in the development, stem cell differentiation, and tumorigenesis","volume":"232","author":"Chen","year":"2017","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.canlet.2025.217714_bib29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.molmed.2008.03.004","article-title":"Epithelial-mesenchymal transition and the invasive potential of tumors","volume":"14","author":"Gavert","year":"2008","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.canlet.2025.217714_bib30","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1002\/ijc.34836","article-title":"N-cadherin: a diagnostic marker to help discriminate primary liver carcinomas from extrahepatic carcinomas","volume":"154","author":"Gerber","year":"2024","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2025.217714_bib31","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1111\/febs.14090","article-title":"Metabolic reprogramming and epithelial-to-mesenchymal transition in cancer","volume":"284","author":"Sciacovelli","year":"2017","journal-title":"FEBS J."},{"key":"10.1016\/j.canlet.2025.217714_bib32","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/hep.31094","article-title":"Modulation of biliary cancer chemo-resistance through MicroRNA-mediated rewiring of the expansion of CD133+ cells","volume":"72","author":"Carotenuto","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2025.217714_bib33","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.freeradbiomed.2013.07.034","article-title":"Inflammation-related DNA damage and expression of CD133 and Oct3\/4 in cholangiocarcinoma patients with poor prognosis","volume":"65","author":"Thanan","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.canlet.2025.217714_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1250215","article-title":"Single-cell RNA sequencing reveals cancer stem-like cells and dynamics in tumor microenvironment during cholangiocarcinoma progression","volume":"11","author":"Golino","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2025.217714_bib35","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jhep.2020.12.031","article-title":"Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma","volume":"74","author":"Raggi","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2025.217714_bib36","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/j.gastro.2016.11.048","article-title":"Liver cancer cell of origin, molecular class, and effects on patient prognosis","volume":"152","author":"Sia","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2025.217714_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2023.102054","article-title":"MicroRNA-451a inhibits gemcitabine-refractory biliary tract cancer progression by suppressing the MIF-mediated PI3K\/AKT pathway","volume":"34","author":"Obata","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.canlet.2025.217714_bib38","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.chembiol.2021.02.014","article-title":"Y box binding protein 1 inhibition as a targeted therapy for ovarian cancer","volume":"28","author":"Tailor","year":"2021","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.canlet.2025.217714_bib39","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3892\/ijmm.2017.3113","article-title":"Osthole induces apoptosis and suppresses proliferation via the PI3K\/Akt pathway in intrahepatic cholangiocarcinoma","volume":"40","author":"Zhu","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.canlet.2025.217714_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167521","article-title":"Kinase library screening identifies IGF-1R as an oncogenic vulnerability in intrahepatic cholangiocarcinoma stem-like cells","volume":"1871","author":"Rattanasinchai","year":"2025","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"key":"10.1016\/j.canlet.2025.217714_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ph17010009","article-title":"CP-673451, a selective platelet-derived growth factor receptor tyrosine kinase inhibitor, induces apoptosis in opisthorchis viverrini-associated cholangiocarcinoma via Nrf2 suppression and enhanced ROS","volume":"17","author":"Duangdara","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.canlet.2025.217714_bib42","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1172\/JCI76452","article-title":"WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited","volume":"125","author":"Boulter","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2025.217714_bib43","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/liv.14747","article-title":"LGR5 induces beta-catenin activation and augments tumour progression by activating STAT3 in human intrahepatic cholangiocarcinoma","volume":"41","author":"Kawasaki","year":"2021","journal-title":"Liver Int."},{"key":"10.1016\/j.canlet.2025.217714_bib44","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1002\/tox.23826","article-title":"TRIM29 facilitates proliferation and malignancy of cholangiocarcinoma cells by activating MAPK and beta-catenin pathways","volume":"38","author":"Yang","year":"2023","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.canlet.2025.217714_bib45","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.ajpath.2019.05.014","article-title":"The expression of yes-associated protein (YAP) maintains putative cancer stemness and is associated with poor prognosis in intrahepatic cholangiocarcinoma","volume":"189","author":"Sugiura","year":"2019","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.canlet.2025.217714_bib46","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.hbpd.2022.03.006","article-title":"Verteporfin synergizes the efficacy of anti-PD-1 in cholangiocarcinoma","volume":"21","author":"Fu","year":"2022","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.canlet.2025.217714_bib47","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.15252\/embj.201490379","article-title":"Aerobic glycolysis tunes YAP\/TAZ transcriptional activity","volume":"34","author":"Enzo","year":"2015","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2025.217714_bib48","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1186\/s12885-016-2919-4","article-title":"Aberrant activation of Notch signaling in extrahepatic cholangiocarcinoma: clinicopathological features and therapeutic potential for cancer stem cell-like properties","volume":"16","author":"Aoki","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2025.217714_bib49","article-title":"PI3K signaling-regulated metabolic reprogramming: from mechanism to application","volume":"1878","author":"Su","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.canlet.2025.217714_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3689","article-title":"YBX1 promotes stemness and cisplatin insensitivity in intrahepatic cholangiocarcinoma via the AKT\/beta-catenin axis","volume":"26","author":"Shi","year":"2024","journal-title":"J. Gene Med."},{"key":"10.1016\/j.canlet.2025.217714_bib51","first-page":"14","article-title":"Wnt\/beta-Catenin signaling as a driver of stemness and metabolic reprogramming in hepatocellular carcinoma","author":"Leung","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2025.217714_bib52","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3389\/fcell.2020.00417","article-title":"CD44v9 induces stem cell-like phenotypes in human cholangiocarcinoma","volume":"8","author":"Suwannakul","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2025.217714_bib53","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.150155","article-title":"Notch stimulates growth by direct regulation of genes involved in the control of glycolysis and the tricarboxylic acid cycle","volume":"6","author":"Slaninova","year":"2016","journal-title":"Open Biol"},{"key":"10.1016\/j.canlet.2025.217714_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.116021","article-title":"Targeting metabolic reprogramming in hepatocellular carcinoma to overcome therapeutic resistance: a comprehensive review","volume":"170","author":"Wang","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2025.217714_bib55","doi-asserted-by":"crossref","first-page":"8274","DOI":"10.1002\/jcp.27679","article-title":"Stromal-induced downregulation of miR-1247 promotes prostate cancer malignancy","volume":"234","author":"Taddei","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.canlet.2025.217714_bib56","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1053\/j.gastro.2023.02.045","article-title":"Refining classification of cholangiocarcinoma subtypes via proteogenomic integration reveals new therapeutic prospects","volume":"164","author":"Cho","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2025.217714_bib57","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fmed.2020.00113","article-title":"Role of glucose metabolism reprogramming in the pathogenesis of cholangiocarcinoma","volume":"7","author":"Pant","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.canlet.2025.217714_bib58","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41419-018-0494-0","article-title":"PGC1alpha promotes cholangiocarcinoma metastasis by upregulating PDHA1 and MPC1 expression to reverse the Warburg effect","volume":"9","author":"Dan","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2025.217714_bib59","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1038\/s41598-021-81172-0","article-title":"Metformin exerts anti-cancerogenic effects and reverses epithelial-to-mesenchymal transition trait in primary human intrahepatic cholangiocarcinoma cells","volume":"11","author":"Di Matteo","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2025.217714_bib60","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1053\/j.gastro.2023.11.302","article-title":"Fibroblast-derived lysyl oxidase increases oxidative phosphorylation and stemness in cholangiocarcinoma","volume":"166","author":"Lewinska","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2025.217714_bib61","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1111\/cas.16140","article-title":"FAXC interacts with ANXA2 and SRC in mitochondria and promotes tumorigenesis in cholangiocarcinoma","volume":"115","author":"Fujimori","year":"2024","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2025.217714_bib62","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3109\/10715762.2016.1172071","article-title":"Oxidative stress balance is dysregulated and represents an additional target for treating cholangiocarcinoma","volume":"50","author":"Uchida","year":"2016","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.canlet.2025.217714_bib63","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/hep.32099","article-title":"CAFs shape myeloid-derived suppressor cells to promote stemness of intrahepatic cholangiocarcinoma through 5-lipoxygenase","volume":"75","author":"Lin","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2025.217714_bib64","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40170-021-00249-6","article-title":"Sulfasalazine modifies metabolic profiles and enhances cisplatin chemosensitivity on cholangiocarcinoma cells in in vitro and in vivo models","volume":"9","author":"Thanee","year":"2021","journal-title":"Cancer Metabol."},{"key":"10.1016\/j.canlet.2025.217714_bib65","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13046-018-0784-5","article-title":"Emerging role of lipid metabolism alterations in Cancer stem cells","volume":"37","author":"Yi","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2025.217714_bib66","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-78539-0","article-title":"BEX2 suppresses mitochondrial activity and is required for dormant cancer stem cell maintenance in intrahepatic cholangiocarcinoma","volume":"10","author":"Tamai","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2025.217714_bib67","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1016\/j.celrep.2020.03.005","article-title":"c-Src promotes tumorigenesis and tumor progression by activating PFKFB3","volume":"30","author":"Ma","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2025.217714_bib68","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40170-021-00266-5","article-title":"Integration of global metabolomics and lipidomics approaches reveals the molecular mechanisms and the potential biomarkers for postoperative recurrence in early-stage cholangiocarcinoma","volume":"9","author":"Padthaisong","year":"2021","journal-title":"Cancer Metabol."},{"key":"10.1016\/j.canlet.2025.217714_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217076","article-title":"Metabolic reprogramming in tumor immune microenvironment: impact on immune cell function and therapeutic implications","volume":"597","author":"Liu","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217714_bib70","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/s41418-019-0292-y","article-title":"Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications","volume":"26","author":"Nazio","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2025.217714_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217285","article-title":"Autophagy and cancer therapy","volume":"605","author":"Pimentel","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217714_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14235912","article-title":"Regulation of metabolic plasticity in cancer stem cells and implications in cancer therapy","volume":"14","author":"Papadaki","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2025.217714_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113588","article-title":"Loss of alpha-1,2-mannosidase MAN1C1 promotes tumorigenesis of intrahepatic cholangiocarcinoma through enhancing CD133-FIP200 interaction","volume":"42","author":"Wei","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2025.217714_bib74","doi-asserted-by":"crossref","first-page":"76238","DOI":"10.18632\/oncotarget.12803","article-title":"Resistance of glioma cells to nutrient-deprived microenvironment can be enhanced by CD133-mediated autophagy","volume":"7","author":"Sun","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2025.217714_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107069","article-title":"Anti-tumour effect of the fourth-generation chimeric antigen receptor T cells targeting CD133 against cholangiocarcinoma cells","volume":"89","author":"Sangsuwannukul","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.canlet.2025.217714_bib76","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41392-023-01705-z","article-title":"Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: from mechanism to clinical studies","volume":"8","author":"Bahar","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2025.217714_bib77","article-title":"N-acetylcysteine attenuates ischemia-reperfusion-induced apoptosis and autophagy in mouse liver via regulation of the ROS\/JNK\/Bcl-2 pathway","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2025.217714_bib78","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.mod.2009.06.1082","article-title":"JNK protects Drosophila from oxidative stress by trancriptionally activating autophagy","volume":"126","author":"Wu","year":"2009","journal-title":"Mech. Dev."},{"key":"10.1016\/j.canlet.2025.217714_bib79","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a018713","article-title":"Erasers of histone acetylation: the histone deacetylase enzymes","volume":"6","author":"Seto","year":"2014","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.canlet.2025.217714_bib80","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.1038\/sj.onc.1210610","article-title":"Histone deacetylases and cancer","volume":"26","author":"Glozak","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2025.217714_bib81","article-title":"Chidamide suppresses the growth of cholangiocarcinoma by inhibiting HDAC3 and promoting FOXO1 acetylation","volume":"2022","author":"Li","year":"2022","journal-title":"Stem Cell. Int."},{"key":"10.1016\/j.canlet.2025.217714_bib82","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17804-1","article-title":"Dysregulation of iron metabolism in cholangiocarcinoma stem-like cells","volume":"7","author":"Raggi","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2025.217714_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217092","article-title":"A novel protein encoded by circFOXP1 enhances ferroptosis and inhibits tumor recurrence in intrahepatic cholangiocarcinoma","volume":"598","author":"Wang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2025.217714_bib84","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1111\/liv.15462","article-title":"FBXO31 sensitizes cancer stem cells-like cells to cisplatin by promoting ferroptosis and facilitating proteasomal degradation of GPX4 in cholangiocarcinoma","volume":"42","author":"Zhu","year":"2022","journal-title":"Liver Int."},{"key":"10.1016\/j.canlet.2025.217714_bib85","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s41698-024-00783-8","article-title":"ACSL3 is an unfavorable prognostic marker in cholangiocarcinoma patients and confers ferroptosis resistance in cholangiocarcinoma cells","volume":"8","author":"Sae-Fung","year":"2024","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.canlet.2025.217714_bib86","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/mc.23697","article-title":"GOLPH3 promotes tumor malignancy via inhibition of ferroptosis by upregulating SLC7A11 in cholangiocarcinoma","volume":"63","author":"Yin","year":"2024","journal-title":"Mol. Carcinog."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525002800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525002800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T22:59:48Z","timestamp":1760741988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383525002800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":86,"alternative-id":["S0304383525002800"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217714","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic reprogramming in cholangiocarcinoma cancer stem cells: Emerging therapeutic paradigms","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.217714","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"217714"}}